← Back
$SRPT All transactions

Sarepta Therapeutics, Inc.

A

$ Value

Shares

Price

Filed

Dec 19

Insider

Name

Chambers Michael Andrew

Title

CIK

0001932527

Roles

Director

Transaction Details

Transaction Date

2025-12-18

Code

A

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

On December 10, 2025, the Reporting Person and the Company entered into an exchange agreement related to the exchange by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the "2027 Notes") for a combination of (i) $20,000,000 in aggregate principal amount of the Company's 4.875% Convertible Senior Notes due 2030 (the "2030 Notes") and (ii) $2,170,006.66 in cash in a private exchange with the Company. The exchange closed on December 18, 2025. | The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election. | The 2030 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 1, 2030, provided that certain convertibility conditions are met. On or after March 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date (August 29, 2030), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2030 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election.

Filing Info

Accession No.

0001193125-25-326980

Form Type

4

Issuer CIK

0000873303

Chambers Michael Andrew's History

Date Ticker Type Value
2025-12-18 SRPT D
2025-12-18 SRPT A

Other Insiders at SRPT (90d)

No other insider activity at this issuer in the last 90 days.